Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

Abstract

In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival. (Current Controlled Trials number, ISRCTN93793971 [controlled-trials.com].).

Keywords

MedicineEpirubicinRegimenPerioperativeCisplatinChemotherapyCancerSurgeryInternal medicineAdenocarcinomaOncologyCyclophosphamide

Affiliated Institutions

Related Publications

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

Justin S. Waters , A. Norman , David Cunningham +12 more

We report the final results of a prospectively randomized study that compared the combination of epirubicin, cisplatin and protracted venous infusion fluorouracil (5-FU) (ECF re...

1999 British Journal of Cancer 278 citations

Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971)

David Cunningham , W H Allum , SP Stenning +1 more

4001 Background: Epirubicin, Cisplatin and infused 5-FU (ECF) shows significant benefit in advanced oesophagogastric cancer, particularly locally advanced disease. This trial wa...

2005 Journal of Clinical Oncology 117 citations

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Salah‐Eddin Al‐Batran , Nils Homann , Claudia Pauligk +54 more

Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy of the docetaxel-ba...

2019 The Lancet 2355 citations

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb , David Cunningham , J.H. Scarffe +16 more

PURPOSE We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous infusion fluorouracil (5-FU) (ECF...

1997 Journal of Clinical Oncology 871 citations

Prospective Randomized Trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) With Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer

Paul J. Ross , M. Nicolson , David Cunningham +9 more

PURPOSE: We report the results of a prospectively randomized study that compared the combination of epirubicin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU)...

2002 Journal of Clinical Oncology 481 citations

Publication Info

Year: 2006
Type: article
Volume: 355
Issue: 1
Pages: 11-20
Citations: 6200
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

6200

OpenAlex

Cite This

APA Style

                            
                                
                                    David Cunningham, 
                                
                                    William Allum, 
                                
                                    Sally Stenning
                                
                                et al.
                            
                            (2006). 
                            Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. 
                            New England Journal of Medicine
                            , 355
                            (1)
                            , 11-20.
                            https://doi.org/10.1056/nejmoa055531
                        

Identifiers

DOI: 10.1056/nejmoa055531